Aynacioglu A S, Cascorbi I, Mrozikiewicz P M, Roots I
Institute of Clinical Pharmacology, University Clinic Charité, Humboldt University of Berlin, Germany.
Pharmacogenetics. 1997 Aug;7(4):327-31. doi: 10.1097/00008571-199708000-00008.
A group of 303 unrelated Turkish subjects from south-east Anatolia was genotyped for seven NAT2 mutations by polymerase chain reaction-restriction fragment length polymorphism. Genotypes associated with slow acetylation were identified in 57.4% (95%-confidence limits, 51.6%-63.1%). Allele frequencies were NAT2*4 (wild type, 23.1%), *5A (1.3%), *5B (35.6%), *5C (4.8%), *6A (30.5%), *7B (4.5%), and *12A (0.2%). A mutation G191A was not detected. Ambiguous mutation linkages were checked by molecular genetic linkage analysis and DNA sequencing. NAT2-alleles in Turks are similarly distributed as in Middle European ethnicities.
通过聚合酶链反应-限制性片段长度多态性技术,对来自安纳托利亚东南部的303名无亲缘关系的土耳其受试者进行了7种NAT2突变的基因分型。在57.4%(95%置信区间,51.6%-63.1%)的受试者中鉴定出与慢乙酰化相关的基因型。等位基因频率分别为NAT2*4(野生型,23.1%)、*5A(1.3%)、*5B(35.6%)、*5C(4.8%)、*6A(30.5%)、7B(4.5%)和12A(0.2%)。未检测到G191A突变。通过分子遗传连锁分析和DNA测序检查了模糊的突变连锁。土耳其人的NAT2等位基因分布与中欧种族相似。